ABBV vs AMZN
AbbVie Inc. vs Amazon.com, Inc.
ABBV
AbbVie Inc.
$220.75+0.32%
AMZN
Amazon.com, Inc.
$242.60-1.57%
Key Metrics Comparison
| ABBV | Metric | AMZN |
|---|---|---|
| $220.75 | Price | $242.60 |
| $390.11B | Market Cap | $2.59TBetter |
| 167.23 | P/E Ratio | 34.27Better |
| $1.32 | EPS | $7.08Better |
| +0.32%Better | Day Change | -1.57% |
| $244.81 | 52W High | $258.60 |
| $164.39 | 52W Low | $161.38 |
| 4,785,505 | Volume | 35,773,724Better |
| 5,788,224 | Avg Volume | 44,943,940Better |
About AbbVie Inc.
Healthcare | Drug Manufacturers - General
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for th...
About Amazon.com, Inc.
Consumer Cyclical | Specialty Retail
Amazon.com, Inc. engages in the retail sale of consumer products and subscriptions through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). Its products offered through its store...